Print Page   |   Contact Us   |   Your Cart   |   Sign In
Sign In
Sign In securely
Breaking News
News & Press: Daily Updates

Takeda launches Zika vaccine trial; Chembio lands contract for rapid test

Tuesday, November 28, 2017   (0 Comments)

In the latest Zika developments, Japan-based Takeda today announced the launch of a phase 1 trial of its Zika virus vaccine, and Chembio Diagnostics, based in New York City, said it has been awarded a contract from UNICEF for the purchase of its Zika point-of-care testing system.


OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2017. Sponsorship does not imply endorsement by OSAP of a company's products or services.